Synaptobrevin, a membrane protein of synaptic vesicles that plays a key role in exocytosis, occurs in two closely related isoforms, synaptobrevin I and II. We have analyzed the axonal transport of both isoforms in sciatic nerve and spinal roots. When fast axonal transport was interrupted by crushing, the proteins accumulated continuously proximal to the crush. Accumulation also was observed distal to the crush, but to a lesser extent (47 and 63% of the proximal accumulation for synaptobrevin I and II, respectively). lmmunoelectron microscopy revealed that, proximal to the crush, synaptobrevin I and II were associated with small clear vesicles reminiscent of typical synaptic vesicles. Distal to the crush, membranes positive for synaptobrevin I or II were more heterogeneous, including larger membrane profiles that may represent endosomes.
In spinal cord, synaptobrevin I and II were colocalized in many terminals. However, labeling for synaptobrevin I was more intense in ventral horn nerve terminals than in dorsal horn terminals, whereas labeling for synaptobrevin II was stronger in dorsal than in ventral horn terminals. Motor endplates contained only synaptobrevin I. In the sciatic nerve, synaptobrevin I was present predominantly in large, myelinated axons, whereas synaptobrevin II was virtually absent, but abundant in small-and medium-sized axons. Lumbar sympathectomy, ventral rhizotomy, and double-labeling studies confirmed that synaptobrevin I is present predominantly in motor neurons, whereas synaptobrevin II is present in adrenergic and sensory neurons.
We conclude that synaptobrevin I and II are transported bidirectionally by fast axonal transport and are expressed heterogeneously in different neurons in the peripheral nervous system of the adult rat, suggesting that these isoforms have special functional roles in different sets of neurons.
Key words: synaptobrevins; axonal transport; synaptic vesicles; motor neurons; sympathetic adrenergic neuron; sensory neuron; immunofluorescence; confocal laser scanning microscopy Communication between neurons occurs at specialized contact areas known as the synapses and is mediated by neurotransmitters that are released by exocytosis of synaptic vesicles. The vesicle membrane is then retrieved by endocytosis and regenerated, probably involving passage through clathrin-coated vesicles and endosomal intermediate compartments (for review, see Jahn and Siidhof, 1994; .
Recently, major progress has been made in our understanding of the molecular mechanisms that underlie exocytotic membrane fusion. Exocytosis is mediated by a set of conserved membrane proteins that interact with soluble factors, termed N-ethylmaleimide-sensitive factors (NSF), and with soluble NSF attachment proteins (SNAPS). The membrane proteins are synaptobrevin (also referred to as vesicle-associated membrane protein) and the synaptic membrane proteins syntaxin and SNAP-25. Recent evidence suggests that most, and possibly all, intracellular fusion events in eukaryotic cells are mediated by relatives of these membrane proteins (for review, see Rothman and Warren, 1994; Ferro-Novick and Jahn, 1994) .
Synaptobrevin is an integral membrane protein of -18,000 Da anchored to the vesicle membrane by means of a single transmembrane domain at the C-terminal end of the molecule, and highly conserved during evolution (Siidhof et al., 1989a) . Synaptobrevin is selectively cleaved by clostridial neurotoxins that potently inhibit exocytosis (Link et al., 1992; Schiavo et al., 1992; Yamasaki et al., 1994a-c) , thus demonstrating that the protein is essential for exocytotic membrane fusion. Although the mechanism of action of synaptobrevin remains to be established, it is likely that it mediates its activity by specific protein-protein interactions Pevsner et al., 1994) . Recent data suggest that it forms a stable prefusion complex with the membrane proteins SNAP-25 and syntaxin 1 after vesicle docking, whereas in the resting state it is controlled by synaptophysin, a major membrane protein of synaptic vesicles Darner and Creutz, 1994; Edelmann et al., 1995) .
In the mammalian nervous system, two isoforms of synaptobrevin (synaptobrevin I and II) have been detected. They are highly homologous to each other but are encoded by two separate genes (Elferink et al., 1989) . Such isoform variety is common for synaptic vesicle membrane proteins (for review, see Jahn and Siidhof, 1994) , but its functional significance is unknown. In addition, a highly homologous protein, cellubrevin, has recently been characterized. In contrast to synaptobrevin I and II, cellubrevin is Siidhof et al., 1989b; Geppert et al., 1991; Baldini et al., 1992; Fykse et al., 1993) , synaptobrevin I and II are differentially expressed in the brain. Using in situ hybridization, Trimble et al. (1990) found that synaptobrevin I was expressed in some CNS nuclei, modulating somatomotor functions, whereas synaptobrec vin II, the predominant isoform in the CNS, was expressed preferably in nuclei associated with autonomic, sensory, and integrative functions. However, a study addressing the detailed distribution of synaptobrevin I and II proteins has not yet been carried out.
In the present study, we have investigated the distribution of synaptobrevin I and II in the peripheral nervous system. Our results show that both proteins are transported by fast anterograde and retrograde axonal transport but that they are expressed differentially in different neurons.
MATERIALS AND METHODS
Adult male Sprague-Dawley rats (200-250 gm) were used. Under ether anesthesia, the sciatic nerves were exposed bilaterally and double-crushed as described earlier (Dahlstrom et al., 1989) . To study accumulations of vesicle components in the motor or sensory neurons, the ventral and dorsal roots were crush-operated using watchmakers' forceps. The operation was performed via a dorsal approach as described in detail by Boiij et al. (1989) .
To investigate the differential distribution of synaptobrevins in autonomic sympathetic, motor, and sensory systems, the following operations were performed with the purpose of studying the neuronal origin.
(1) Lumbar sympathectomy was performed by removing the lumbar sympathetic chain bilaterally (Dahlstrom et al., 1985) . This procedure removed >95% of the postganglionic axons in the sciatic nerve, leaving sensory and somatic motor fibers intact. (2) Motor rhizotomy was achieved by cutting the ventral roots L2-L6 (the roots that form the sciatic nerve). The sympathectomized or rhizotomized rats were allowed to survive for 3 or 8 d. Six hours before sacrifice, the sciatic nerves of the rats were double-crushed as described above. All procedures and handling of the rats were performed in accordance with the rules of the Animal Ethical Committee in Goteborg.
After transcardial perfusion fixation with 4% p-formaldehyde, pH 7.4, under deep mebumal anesthesia, the sciatic nerves, the spinal roots, the gastrocnemic and peroneal muscles, the L3-L6 dorsal root ganglia (DRG), and the lumbar spinal cord were dissected and postfixed in the same fixative for 3 hr. The samples were then rinsed overnight in PBS with 10% sucrose, frozen with compressed CO,, sectioned at 10 pm longitudinally (nerves, roots, DRG, and muscles) or transversely (spinal cord) in a cryostat, and placed on gelatinized glass slides. Indirect immunofluorescence incubations were performed using the following primary antibodies:
(1) Antiqnaptobrevin I, rabbit antiserum produced against the Nterminal of synaptobrevin I (Edelmann et al., 1995) , dilution 1:800;
(2) Anti-synuptobrevin II (Cl 69. I), mouse monoclonal antibody against the N-terminal of synaptobrevin II (Edelmann et al., 1995) , dilution 1:800; (3) Anti-tyrositle hydroxylase (TH), rabbit antiserum raised against TH isolated from human pheochromocytomas (Goldstein et al., 1972) , (donated by Dr. M. Goldstein), dilution 1:800; (4) Anti-substance P (SP; RPN 1572), produced in rabbits against synthetic SP, (Amersham, Buckinghamshire, UK), dilution 1:400.
Single-and double-immunofluorescence incubations of tissue sections were performed as described .
In the sections labeled separately for synaptobrevin I or II, the immunoreactive material accumulating proximally and distally to the crushes was quantitated by cytofluorimetric scanning (CSF) as described in detail earlier (Larsson, 1985; Dahlstrom et al., 1989) . To allow for comparison between different sections, all sections of one series were processed strictly in parallel, using the same solutions for the primary and secondary antibodies. Furthermore, identical scanning sensitivities were used for all sections compared. The reliability of this method was established previously by comparing CSF data with those obtained by enzymatic methods (Larsson, 1985; Dahlstrom et al., 1989) . Figure 3 . Immunoblot of sciatic nerve fragments 6 hr after crush operation. PI and DI represent the proximal and distal fragments (1 mm long) close to the crush; P2 and 02 represent the proximal and distal fragments lo-15 mm away from the crush. The immunoreactivities of synaptobrevin I and II as well as synaptophysin are more intense in Pl and Dl than that in P2 and D2, representing the accumulations that have developed after operation. However, clear bands also can be seen in P2 and D2 (synaptobrevin II), indicating the presence of certain fractions of synaptobrevin II in normal, unlesioned sciatic nerve.
Single-and double-labeled samoles were then studied in a confocal laser s:anning microscope (CLSM)'with a krypton/argon laser (M&C 600, Bio-Rad Laboratories, Richmond, CA), using single-or dual-channel scanning. Colocalization was verified by merging the two channels in two colors and also switching between the channels. In dual-channel scanning, the confocal parameters, such as voltage, offset, gain level, pinhole, and the background level, were set to similar levels for collecting the images in each double-labeled sample. Photographs were taken using Kodak TX 400 film.
Electron ?nzcroscopy. The procedures basically followed those described bv De Camilli et al. (1983) . Brieflv. 6 hr after crush oueration. the sciatic nkrves were immediatel; dissecied and cut into iroximal and distal segments adjacent to the crushes, and then were gently homogenized with small glass-glass grinders. After fixation, the fragments were centrifusated at 16,500 rpm for 45 min, and the pellet was embedded into 1% agarose. Immunogold labeling was performed using Protein A gold (De Camilli et al., 1983) .
Immunoblot experiments.
Six hours after operation, the fresh nerve fragments (1 mm long), from proximal and distal areas close to or lo-15 mm away from the crushes were immediately frozen in liquid nitrogen (cf. Li et al., 1995) . Fragments from five rats were pooled and homogenized in glass-glass homogenizers in sample buffer (containing 1% SDS, 10 mM Tris, 50 mM NaCl, and pepstatin A). SDS-PAGE (5 mg/lane) was performed according to Laemmli (1970) . Immunoblotting was performed according to Towbin et al. (1979) , using radioiodinated Protein A as the detection system. Protein content was determined by the method of Bradford (1976) . When tested by immunoblotting, all synaptobrevin Iand II-specific antibodies reacted only with a single band.
RESULTS

Synaptobrevin I and II are transported by fast axonal transport
To investigate how the synaptobrevins are transported between neuronal cell bodies and distally located synaptic areas, we performed crush operation on sciatic nerves and spinal roots. This technique previously has been shown to block axonal transport while anterogradely and retrogradely transported material accumulates on the proximal and distal side of the crush, respectively (DahlstrGm et al., 1989; Dahlstriim and Li, 1994) . As shown in Figure 1 , a short time (1 hr) after crush operation accumulations of immunoreactive synaptobrevin I and II were observed on both sides of the crushes (Fig. 1B) . The accumulations were not caused by the crushing procedure per se, because accumulations were not The dotted lines mark the border between the two channels. A, Synaptobrevin I-IR is abundant and intensely present in terminals in the ventral horn of the spinal cord, but sparse and weakly fluorescent in the dorsal horn, especially in laminae I an II (arrows). In contrast, synaptobrevin II-positive terminals are abundant in a dense network in the dorsal horn, e.g., laminae I-III, and the region around the central canal (lamina X), but less abundant and weaker in fluorescence intensity in the ventral horn. B, The two proteins are partly colocalized in the terminals of spinal cord (arrows), but terminals positive for either synaptobrevin 1 or II also can be seen (arrowheads) .
C, Synaptobrevin I-IR is localized in large DRG neurons, which are devoid of synaptobrevin II-IR. However, synaptobrevin I and II appear colocalized in small-and medium-sized neurons. Scale bars: 250 Km in A; 25 pm in B and C. registered in nerves that were crushed just before perfusion (Fig. 1A) . Thus, the accumulations had developed during the 1 hr interval between operation and perfusion as a result of fast axonal transport. Clear accumulation of synaptobrevin II appeared after The dotted lines mark the border between the two channe1s.Arrow.s indicate the sites of the crush, and proximal orientation is to the top.A, Synaptobrevin I-IR is intensely in the large axons proximal and distal to the crush of the sciatic nerve, whereas synaptobrevin II-IR is localized in bundles of small-and medium-sized axons. B, Synaptobrevin I-IR is strongly present in the axons proximal and distal to the crush of ventral root. However, only traces of synaptobrevin II-IR can be seen in the axons that are strongly positive for svnantobrevin I. C, Svnaotobrevin I-IR is nresent mainlv inlarge axons and some medium-sized axons in dorsal roots, whereas synaptobrevin II-IR is $esent in thin and medium-sized axons. Scale bars, 106 pm. -crushing, but some synaptobrevin II-positive axons also could be observed in the regions far away from the crushes as well as in the 0 hr crushed nerve sections (Fig. 1A) , indicating that moderate amounts of synaptobrevin II are present in the intact sciatic nerve (also see Fig. 3 ). In animals perfused at later intervals after operation, the amount of accumulated immunoreactivity (IR) increased linearly with time (Figs. 1, 2 ) on both sides of the crush. However, the amount of IR accumulating distally was consistently less than that accumulating proximally (47 and 63% for synaptobrevin I and II, respectively, as quantitated by CSF). This indicates that, similar to other vesicle membrane proteins (Boiij et al., 1986; Li et al., 1992) , the synaptobrevins are degraded partially in the nerve terminals and in the distal zone of the axon.
To confirm the identity of the accumulated immunoreactive material, an immunoblot analysis was performed. Six hours after crush operation, the sciatic nerve was prepared and cut into four small segments of 1 mm each, two proximal (P2 and Pl) and two distal (Dl and D2) of the crush [see Fig. 1 in Li et al. (1995) ]. In the fragments directly adjacent to the crushes (Pl and Dl), high levels of both synaptobrevins were detectable (Fig. 3) . In contrast, the fragments that were sampled lo-15 mm away from the crushes (P2 and D2) contained significantly lower amounts of both proteins. These data demonstrate that the accumulated immunoreactive material corresponds to synaptobrevin I and II proteins. However, it can be noted that the amount of synaptobrevin II-IR is higher in D2 than in P2 for reasons that are still unclear.
Synaptobrevin I and II are differentially distributed in the peripheral nervous system Although both synaptobrevin I and II were demonstrated to be transported by fast axonal transport, the distribution of the two isoforms differed. In the spinal cord, synaptobrevin I immunoreactivity was more intense in the terminals of the ventral horn than of the dorsol horn, whereas synaptobrevin II-IR was more intense in the dorsal horn (laminae I-III) (Fig. 4A) . Both synaptobrevin I-IR and II-IR appeared to be absent from the perikarya of the motor neurons, which is in agreement with the absence of synaptobrevin from perikarya of motoneurons in brainstem (Baumert et al., 1989) . In many cases, synaptobrevin I and II were colocalized in the same terminals (Fig. 4B, awows) , but we also observed terminals that contained either synaptobrevin I or II (Fig. 4B,   arrowheads ).
In the DRG, synaptobrevin I and II were distributed differentially in different sets of neurons. Synaptobrevin I-IR was strong in the large neuronal cell bodies, in which synaptobrevin II-IR was very weak. However, both proteins were present in some smalland medium-sized neurons, although synaptobrevin II-IR was more intense than synaptobrevin I-IR (Fig. 4C ).
These differences in distribution prompted us to compare the localization of both synaptobrevins in the sciatic nerve and in the dorsal and ventral roots at higher resolution. In the sciatic nerve, synaptobrevin I-IR accumulated predominantly in large axons (probably motor axons) at a distance from the crush (Fig. 5A ). Weak immunoreactivity also was found in thin and medium-sized axons. Synaptobrevin II-IR, in contrast, was present mainly in thin and medium-sized axons, which are grouped in bundles and always present their accumulations near the crush . In these axons there was only partial overlap with synaptobrevin I-IR (Fig. 5A) . Moreover, synaptobrevin I-IR accumulated in the axons of ventral roots after crushing, whereas synaptobrevin II-IR was observed only as weakly fluorescent traces on both sides of the crushes (Fig. SB) . In dorsal roots, synaptobrevin I accumulations were present in large axons, whereas synaptobrevin II-IR accumulated in small-and medium-sized axons (Fig. 5C ) which presumably originate from the small neurons in the DRG. Studies in high magnification (100X, NA 1.4) confirmed that synaptobrevin I-IR was present in large axons, whereas synaptobrevin IT-IR was localized in thin and medium-sized axons in sciatic nerve and dorsal root (data not shown).
In the peripheral terminals of the muscles, synaptobrevin I-IR was strong in motor endplates (Fig. M) , whereas synaptobrevin II-IR was very low. Synaptobrevin I-and II-IR were, however. colocalized in muscle spindles (Fig. 6B) and to some extent in perivascular terminals (Fig. 6C) , the latter clearly containing more synaptobrevin II-IR than synaptobrevin I-IR. To study the origin of synaptobrevin I-and II-positive axons in the sciatic nerve, lumbar sympathectomy and ventral rhizotomy were performed by means of surgical removal of the sympathetic adrenergic or motor input to the sciatic nerve, respectively. Three days after ventral rhizotomy, the number of synaptobrevin I-positive axons was drastically reduced, whereas no clear alteration of synaptobrevin II-IR axons was observed. In contrast, after lumbar sympathectomy the number of synaptobrevin II-positive axons in the sciatic nerve was markedly decreased, whereas no obvious change in number of synaptobrevin I-positive axons was noted (data not shown).
To characterize synaptobrevin-containing neurons further, we performed double-labeling experiments with anti-TH and anti-SP. TH, a key enzyme in catecholamine synthesis, was used as a convenient adrenergic marker to identify sympathetic neurons (Goldstein et al., 1972) . As shown in Figure 7 , all TH-positive axons also were positive for synaptobrevin II, confirming that synaptobrevin II was present in sympathetic adrenergic neurons. In addition, double labeling with anti-SP, a sensory marker (H6k-felt et al., 1977) , revealed that SP-IR and synaptobrevin II-IR also were largely colocalized in sensory neurons in both the sciatic nerve and the dorsal roots (Fig. 8E) . In contrast, in the spinal cord, only partial colocalization was observed in the ventral (Fig.  8A , awows) and dorsal horns (laminae I-II) (Fig. 8B, awows) . Many terminals only displayed either synaptobrevin II-IR or SP-IR (Fig. 8A,B, awowheads) . In DRG, substance P-positive neurons also were synaptobrevin II-immunoreactive (Fig. 8C,  arrows) . Some synaptobrevin II-positive perivascular terminals also were positive for SP (Fig. SD) . High-magnification analysis showed that synaptobrevin II-IR was present in a fine granular The dotted lines indicate the border between the two channels. Synaptobrevin II-IR is present in many terminals in the ventral horn (A). In the dorsal horn the number of synaptobrevin II-positive terminals was higher (B). Only partial colocalization with SP-IR is observed (arrows), and many terminals are only positive for either synaptobrevin II or SP (arrowheads).
C, All SP-positive DRG neurons are also positive for synaptobrevin 11 (awows). D, Few synaptobrevin II-positive perivascular terminals are also SP-positive. E, Arrows indicate the site of the crush of the dorsal root; proximal orientation is toward the top. Synaptobrevin II-IR and SP-IRS are essentially colocalized in all the axons. F, Synaptobrevin II-IR appears in fine granules, whereas SP-IR is distributed in large granules. Scale bars: 50 pm in A and B; 100 pm in C-E; 5 pm in F.
pattern, whereas SP-IR appeared in large granules (Fig. 8F) , indicating a difference in the subcellular distribution of synaptobrevin II and SP.
Electron microscopic localization of synaptobrevin I and II in axons and peripheral nerve terminals To determine the subcellular localization of synaptobrevin I and II during axonal transport and in nerve terminals of spinal cord, we performed immunogold labeling of broken cell preparations after embedding in agarose (see Materials and Methods for details). In nerve terminals of spinal cord, labeling for synaptobrevin I was found to be concentrated around small synaptic vesicles (Fig. 9&?) . No labeling of other structures, including the presynaptic membrane, was observed. A very similar picture was obtained when nerve terminals were labeled for synaptobrevin II (Fig. loA) . Again, labeling was observed predominantly around small synaptic vesicles. In addition, some labeling also was observed around a structure reminiscent of large dense-core vesicles (Fig. lOA, arrows) . These data confirm that in the spinal cord both synaptobrevins are associated predominantly with the membrane of synaptic vesicles. We then studied the morphology of synaptobrevin-positive organelles in the sciatic nerve after ligation, using both proximal and distal segments for analysis to differentiate between anterogradely and retrogradely transported orgarielles. In the proximal segment, dense labeling for both synaptobfevin I and II was found around small vesicular profiles with a morphology similar to that of mature synaptic vesicles (Figs. 9C,D, 1OB) . Again, nonspecific labeling was minimal as demonstrated by the absence of labeling on mitochondrial membranes (Fig. 9C,D) . These observations suggest that synaptobrevin is associated with the synaptic vesicles (or their precursors) during anterograde axonal transport. In the distal segments, labeling for both synaptobrevin I and II was found on a more heterogeneous clear vesicle population including some large membrane profiles (Figs. 9E,  1OC) .
DISCUSSION
In the present study, we have investigated the axonal transport of synaptobrevin I and II, two closely homologous neuronal proteins that play an essential role in exocytosis of synaptic vesicles (SSllner et al., 1993a,b) (for review, see Rothman and Warren, 1994; January 1, 1996, 76( Figure 9 . Agarose-embedded immunogold labeling of synaptobrevin I in spinal cord (A and B) and sciatic nerve 6 hr after crush operation, proximal (C and D) and distal (E) to the crush. Synaptobrevin I is associated with synaptic vesicles in nerve terminals (A and B) and also with the vesicles transported from the cell body to terminals (C and D). Dense labeling also can be seen around an organelle in retrograde transport (E). Scale bars, 100 nm. -Novick and Jahn, 1994) . In addition, we have studied the distribution of both proteins in the spinal cord and in the peripheral nervous system. Nerve terminals lack the biosynthetic machinery to make proteins; therefore, all the synaptic vesicle-associated proteins are synthesized in the cell body and exported to the nerve terminals by means of anterograde axonal transport. However, little is known about how these proteins are associated with other proteins or organelles during the transport, ,and to what extent the proteins are recycled to the cell body after the end of their functional life span in the terminal. Our data demonstrate that both isoforms of synaptobrevin are transported by fast axonal transport, both anterogradely and retrogradely. As with other integral membrane proteins of the synaptic vesicle, the percentage of retrogradely transported protein was quite high (47 and 62% for synaptobrevin I and II, respectively). Thus, it appears that although synaptic vesicle constituents are partially degraded during their lifetime in the distal part of the axon, a major portion returns to the neuronal cell body for further processing and/or degradation. Interestingly, nonintegral membrane constituents of synaptic vesicles such as synapsin I (Booj et al., 1986; Dahlstrom et al., 1992) or rab3A (Dahlstrom and Li, 1994; Li et al., 1995) return to a far lower degree. In particular, rab3A is virtually absent from retrogradely accumulating material (Li et al., 1995) , making this protein a specific marker for anterogradely transported precursors of synaptic vesicles.
Ferro
Electron microscopic analysis revealed that anterogradely transported synaptobrevins are highly concentrated on the membrane of small vesicular profiles that are reminiscent of synaptic vesicles. This is in agreement with previous observations that synaptic vesicle-like profiles accumulate on the proximal side of a ligation (Li et al., 1995) and indicates that synaptic vesicle precursors within the axon are morphologically indistinguishable from mature synaptic vesicles. In neuroendocrine cells, it has been demonstrated that synaptic vesicle precursors are first targeted to a constitutive round of recycling before they are regenerated from early endosomes and targeted to the regulated membrane pool (Regnier-Vigouroux et al., 1991) . It remains to be established whether a similar route also is followed in fully differentiated neurons. The striking similarity of the transported organelles with mature synaptic vesicles may suggest that these vesicles are already fully differentiated and are targeted directly to the regulated pool in the nerve terminal. Further studies are required to resolve this issue.
Interestingly, the morphology of the retrogradely transported organelles was different. Frequently, larger membrane cisternae were observed that were not seen on the proximal side. These structures are similar to those observed by Janetzko et al. (1989) which carried the synaptic vesicle protein SV2. This agrees with the notion that retrograde transport involves early and/or late endosomal compartmentation which in non-neuronal cells have been demonstrated to have a similar morphology (Griffith and Gruenberg, 1991) .
Most synaptic vesicle proteins, including the synaptobrevins, consist of multiple isoforms, but the functional significance of different isoforms is not known. As a basis for further functional studies, we have analyzed the distribution of both synaptobrevin isoforms in the peripheral nervous system, where an identification of neuronal pathways often is easier than in the CNS. Our results show that, although Figure 10 . Agarose-embedded immunogold labeling of synaptobrevin II in spinal cord (A) and of sciatic nerve 6 hr after crush operation proximal (B) and distal (C) to the crush. A, Synaptobrevin II is concentrated heavily around small synaptic vesicles in a nerve terminal. The large dense-core vesicles also appear to be labeled (an~ws). The vesicles in three synaptic compartments are devoid of labeling (aster&). B, Synaptobrevin II is associated with vesicles in sciatic nerve proximal to the crush. C, Synaptobrevin II is selectively affiliated with some large membrane profiles recycling to the cell body. Scale bars, 100 nm.
there is some overlap in the distribution of both proteins,,they display a highly specific and differential distribution. Synaptobrevin I is expressed predominantly in large axons of the sciatic nerve, which probably represent efferent motoneurons in the spinal roots and in motor endplates. In contrast, synaptobrevin II is present mainly in thin and medium-sized axons and perivascular terminals, whereas no or very little synaptobrevin II could be detected in large axons and motor endplates. Ventral rhizotomy, lumbar sympathectomy, as well as the double-labeling experiments with anti-synaptobrevin II and anti-TH, a sympathetic adrenergic marker, or anti-SP, a sensory marker, confirmed that synaptobrevin I was present predominantly in motor neurons, whereas synaptobrevin II was abundant in sympathetic adrenergic and sensory neurons.
The significance of this highly specific expression pattern is not clear. However, Fykse et al. (1993) who demonstrated a differ- ential distribution of synaptophysin I and II in the nervous system, presented two alternative hypotheses for the functional meaning of multiple isoforms. One was that isoforms of synaptic vesicle proteins may be isofunctional and expressed in alternative neuronal pathways. The other was that synaptic vesicle protein isoforms may contain functional specializations that distinguish them from each other. Concerning the differences in structural, morphological, and physiological characteristics among motor, sensory, and sympathetic adrenergic neurons, each type of neuron possesses its own specific nature. The motor neurons, insensitive to NGF, form classical synapses (presynaptic, postsynaptic compartments, and synaptic cleft), and the release of vesicle contents is triggered by the influx of Ca'+, which occurs when voltage-gated Ca*+ channels in the terminals are opened in response to depolarization of the terminals by an action potential. However, the NFG-sensitive adrenergic and sensory neurons rarely make "close" synaptic contacts with their effector tissues (vessels, or smooth muscles, etc.). The neurotransmitter release from adrenergic terminals is intermittent (for review, see, Brock and Cunnane, 1993) . It is not clear whether real neurotransmitter release occurs regularly in the sensory terminals; however as a result of axon reflexes, SP has been reported to be released from these terminals (Brodin et al., 1981) . Our data suggest that different isoforms are involved in different release mechanisms.
In the adult rat peripheral nervous system, synaptobrevin I was present predominantly in the motor system, whereas synaptobrevin II, in contrast, appeared in sympathetic adrenergic and sensory neurons. At the light microscopic level, synaptobrevin II-IR showed a distribution similar to SP-IR in axons of the sciatic nerve and the dorsal root (Fig. 8F) . However, the finely granular staining pattern of synaptobrevin II differs from the coarse granular pattern of SP, suggesting that the subcellular distribution of the two proteins may be different. This is not surprising because the neuropeptide SP is confined to large dense-core vesicles, whereas synaptobrevins are abundant residents of small clear vesicles. However, our electron microscopic data demonstrate that some labeling of large dense-core vesicles is obtained with antibodies for synaptobrevin II. This suggests that synaptobrevins are probably present not only on small clear vesicles but also on large dense-core vesicles, in contrast to previous observations (Baumert et al., 1989) . This agrees well with the observation that botulinal neurotoxins specific for synaptobrevin block the release of both classical transmitters and neuropeptides (McMahon et al., 1992) . It is possible that the concentration of synaptobrevin is lower on large dense-core than on small clear vesicles. Further investigation using double immuno-electron microscopy, for example, is necessary to elucidate these questions.
